Treatment
Palonosetron clinical trials
We’re tracking 7 recruiting studies that include Palonosetron, each written for real people, not researchers, below.
Recruiting studies
- NCT07617246RecruitingPhase 2
Preventing nausea from cancer treatment with new medications
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
Hangzhou, ZhejiangAges 18 years+ - NCT05690802Recruiting
Test palonosetron to prevent nausea from chemotherapy
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
Xi'an, Shaan'xiAges 18–75 - NCT07482891RecruitingPhase 4
Preventing nausea and vomiting from multi-day chemo
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07726433RecruitingPhase 2
Preventing nausea from Trastuzumab Rezetecan with two anti-nausea drugs
This trial tests whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can better prevent nausea and vomiting caused by Trastuzumab Rezetecan. If you are starting this cancer treatment, you may be able to join.
TianjinAges 18 years+ - NCT05773950Enrolling by invitation
Triple medicine to prevent nausea after laparoscopic gynecologic surgery
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
Seoul, SeoulAges 19–49 - NCT07699276RecruitingPhase 2
Steroid-sparing nausea drug combo for high-dose chemo
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
BangkokAges 18 years+ - NCT06726291RecruitingPhase 4
Akynzeo for nausea in endometrial cancer chemo
This trial tests if Akynzeo (a nausea medicine) helps prevent vomiting during chemotherapy for endometrial cancer. It is for people starting chemo for the first time.
Brescia, BSAges 18 years+
What Palonosetron is being studied for
Conditions with recruiting Palonosetron studies.
Common questions
- Are there clinical trials studying Palonosetron?
- Yes. Clin2 currently lists 7 recruiting studies that include Palonosetron, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Palonosetron trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Palonosetron an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Palonosetron or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.